U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Vaccines, Blood & Biologics
  3. Blood & Blood Products
  4. Approved Blood Products
  5. Privigen
  1. Approved Blood Products

STN: 125201
Proper Name: Immune Globulin Intravenous (Human), 10% Liquid
Tradename: Privigen
Manufacturer: CSL Behring AG, License #1766
Indication:

For the treatment of:

  • Primary humoral immunodeficiency;
  • Chronic immune thrombocytopenic purpura (ITP) in patients age 15 years and older;
  • Chronic inflammatory demyelinating polyneuropathy (CIDP) in adults.

Product Information

Supporting Documents

Back to Top